- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 501/12 - SeparationPurification
Patent holdings for IPC class C07D 501/12
Total number of patents in this class: 35
10-year publication summary
|
7
|
3
|
0
|
0
|
1
|
0
|
3
|
1
|
1
|
0
|
| 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Hainan Lingkang Pharmaceutical Co., Ltd. | 17 |
11 |
| Tianjin University | 900 |
7 |
| Basilea Pharmaceutica AG | 56 |
3 |
| DSM Sinochem Pharmaceuticals Netherlands B.V. | 60 |
2 |
| Hainan Hailing Chemipharma Corporation Ltd. | 13 |
2 |
| Ncpc Hebei Huamin Pharmaceutical Co., Ltd. | 2 |
2 |
| Aurobindo Pharma Ltd | 134 |
1 |
| Lupin Limited | 438 |
1 |
| Chengde Medical College | 5 |
1 |
| Qilu Anti Pharmaceutical Co. Ltd. | 1 |
1 |
| Tibet Bangchen Pharmaceutical Group Co., Ltd. | 1 |
1 |
| China Union Chempharma (Suzhou) Co., Ltd. | 1 |
1 |
| The Third Suzhou Pharmaceutical Laboratory | 1 |
1 |
| Basilea Pharmaceutica International AG, Allschwil | 1 |
1 |
| Other owners | 0 |